Delivery Order SPE2DE24DA010-SPE2D625F3JDK
- Not listed
- Abbott Laboratories Inc.'s Abbott Vascular Inc. division has been awarded a fixed-price delivery order valued at $10,500 by the Medical Supply Chain division of the Department of Defense on September 12, 2025, with an ultimate completion date of September 17, 2025. The contract, which carries no set-aside designation indicating full and open competition, is for the AVEIR leadless pacemaker system and will be performed in Santa Clara, California. This delivery order represents a task order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350.00 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The contract, which involves no set-aside designation and therefore represents full and open competition, is for the delivery of the Aveir Leadless Pacemaker system to be performed at the contractor's facility in Santa Clara,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $18,600 fixed-price delivery order with economic price adjustment for Aveir Leadless Pacemakers, with an ultimate completion date of July 23, 2025. The contract was awarded without a set-aside designation on July 18, 2025, indicating full and open competition. Performance will take place in Santa Clara, California, with funding provided by the Defense Logistics Agency's Medical Supply Chain division, which...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $49.8K by the Department of Defense's Medical Supply Chain for the delivery of Aveir Leadless Pacemakers. The contract, awarded on August 1, 2025, with an ultimate completion date of August 6, 2025, will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and open competition. The award represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350.00 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as AVEIR (a reference to Abbott's Aveir Leadless Pacemaker technology), will be performed in Santa Clara, California, and was awarded without a set-aside designation, indicating full and open competition. This...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $9,500 fixed-price delivery order (Contract No. 4569453256) for AVEIR products by the Defense Logistics Agency's Medical Supply Chain on September 12, 2025, with an ultimate completion date of September 17, 2025. The work will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and open competition among qualified vendors. Abbott Vascular has...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $89,535.00 on September 12, 2025, for the supply of AVEIR medical devices. This fixed-price contract with economic price adjustment adjustment is scheduled for completion by September 17, 2025, and will be performed in Santa Clara, California. The award was issued by the Medical Supply Chain division of a defense-focused federal agency with no set-aside designation, indicating full and...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order with economic price adjustment totaling $9,500 by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as AVEIR and issued on July 29, 2025, with an ultimate completion date of August 1, 2025, will be performed in Santa Clara, California. This delivery order was awarded without set-aside designation, indicating full and open competition among...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $2,500 delivery order on July 28, 2025, for leadless accessories to support federal healthcare operations. The contract, which carries no set-aside designation and operates under fixed-price pricing with economic price adjustment terms, is funded by the Medical Supply Chain division of the Department of Defense and will be performed in Santa Clara, California. This delivery order represents a continuation of...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $2,000 delivery order for leadless accessories by the Medical Supply Chain division of the Department of Defense on September 12, 2025, with an ultimate completion date of September 17, 2025. The contract is a fixed-price delivery order with economic price adjustment provisions and was awarded without a set-aside designation, indicating full and open competition. Performance will take place in Santa Clara,...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F3JDKDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $9,500 fixed-price delivery order with economic price adjustment for the AVEIR leadless pacemaker system on September 12, 2025. The contract, issued by the Defense Logistics Agency's Medical Supply Chain organization, will be performed in Santa Clara, California, with an ultimate completion date of September 17, 2025. This delivery order was awarded without a set-aside designation, indicating full and open competition among qualified vendors. This award reflects Abbott's established role as a critical supplier of advanced cardiovascular medical technologies to federal defense and healthcare systems. The AVEIR leadless pacemaker represents a sophisticated implantable cardiac device that supports complex cardiac procedures within the VA and Defense Logistics Agency medical procurement ecosystem. Abbott has demonstrated substantial capacity in this market through multiple significant indefinite delivery contracts, including a $117.1 million comprehensive cardiovascular technologies agreement with the Defense Logistics Agency, positioning the company as a strategic vendor for federal cardiology and cardiac care initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 9/12/25 |